{"id":"tc","safety":{"commonSideEffects":[{"rate":"60–90","effect":"Neutropenia"},{"rate":"50–80","effect":"Alopecia"},{"rate":"40–60","effect":"Nausea and vomiting"},{"rate":"40–50","effect":"Fatigue"},{"rate":"20–40","effect":"Mucositis"},{"rate":"10–20","effect":"Peripheral neuropathy"},{"rate":"5–15","effect":"Febrile neutropenia"}]},"_chembl":null,"_dailymed":{"setId":"10320da4-0c64-4d03-e063-6394a90a1923","title":"TECHNEGAS (KIT FOR THE PREPARATION OF TECHNETIUM TC 99M-LABELED CARBON INHALATION AEROSOL) KIT [CYCLOMEDICA AUSTRALIA PTY LIMITED]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Docetaxel is a taxane that stabilizes microtubules and prevents their disassembly, disrupting mitotic spindle formation. Cyclophosphamide is an alkylating agent that cross-links DNA, preventing replication. Together, they provide complementary cytotoxic mechanisms commonly used in breast cancer treatment.","oneSentence":"TC is a chemotherapy regimen combining docetaxel and cyclophosphamide, which work synergistically to inhibit cell division and induce apoptosis in cancer cells.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:37:40.924Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Breast cancer (adjuvant and neoadjuvant treatment)"}]},"trialDetails":[{"nctId":"NCT07495397","phase":"NA","title":"Single-arm, Prospective Clinical Trial of Efficacy and Safety of Daphnetin Capsules Combined With TC Regimen for Targeted Maintenance Therapy After Initial Treatment of Stage III-IV Epithelial Ovarian Cancer (RO/R1)","status":"RECRUITING","sponsor":"The First Hospital of Jilin University","startDate":"2025-11-01","conditions":"Epithelial Ovarian Cancer","enrollment":98},{"nctId":"NCT06982222","phase":"PHASE1","title":"Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-03-31","conditions":"Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma","enrollment":24},{"nctId":"NCT07284121","phase":"","title":"A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-07-17","conditions":"Lung Cancer, Hepatocellular Carcinoma","enrollment":700},{"nctId":"NCT07159074","phase":"PHASE2","title":"Repurposing Tilmanocept for Cardiac Sarcoidosis","status":"RECRUITING","sponsor":"Duke University","startDate":"2025-09-17","conditions":"Cardiac Sarcoidosis","enrollment":15},{"nctId":"NCT03372811","phase":"PHASE2","title":"Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial)","status":"COMPLETED","sponsor":"Psoriasis Research Institute of Guangzhou","startDate":"2015-06-11","conditions":"Psoriasis Vulgaris, Topical Administration","enrollment":88},{"nctId":"NCT04432207","phase":"PHASE1","title":"A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer","status":"TERMINATED","sponsor":"Imugene Limited","startDate":"2020-11-30","conditions":"Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV","enrollment":24},{"nctId":"NCT05176808","phase":"NA","title":"Telehealth Parent-Implemented Intervention for Young Children With Autism Spectrum Disorder (ASD)","status":"RECRUITING","sponsor":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","startDate":"2022-02-07","conditions":"Autism Spectrum Disorder, Autistic Disorder, Active Autistic Disorder","enrollment":188},{"nctId":"NCT07488819","phase":"","title":"Imaging Phosphodiesterase 4B (PDE4B) in People With Psychiatric Disorders With Positron Emission Tomography (PET) and the Radiotracer [18F]PF974","status":"NOT_YET_RECRUITING","sponsor":"Yale University","startDate":"2026-03-01","conditions":"Post-Traumatic Stress Disorder, PTSD, Alcohol Use Disorder (AUD)","enrollment":160},{"nctId":"NCT05570617","phase":"NA","title":"Transition to Adulthood Through Coaching and Empowerment","status":"COMPLETED","sponsor":"McMaster University","startDate":"2022-11-21","conditions":"Juvenile Idiopathic Arthritis, Inflammatory Bowel Diseases","enrollment":27},{"nctId":"NCT07476001","phase":"PHASE2","title":"Phase 2a Study of High-Dose Testosterone Followed by Radioligand Therapy in mCRPC","status":"RECRUITING","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2026-03","conditions":"Metastatic Castration-resistant Prostate Cancer","enrollment":12},{"nctId":"NCT06357533","phase":"PHASE3","title":"Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2024-04-11","conditions":"Non-Small Cell Lung Cancer","enrollment":675},{"nctId":"NCT03996850","phase":"","title":"SPECT/CT for the Characterization of Renal Masses","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2018-12-07","conditions":"Kidney Neoplasm, Renal Mass","enrollment":102},{"nctId":"NCT07457541","phase":"PHASE1","title":"Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI","status":"ACTIVE_NOT_RECRUITING","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2026-02-26","conditions":"Lung Cancer (Locally Advanced or Metastatic), Pancreas Cancer, Metastatic, Breast Cancer (Locally Advanced or Metastatic)","enrollment":15},{"nctId":"NCT03028311","phase":"PHASE1","title":"Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-01-09","conditions":"Metastatic Liver Carcinoma, Stage IV Liver Cancer, Stage IVA Liver Cancer","enrollment":12},{"nctId":"NCT02324387","phase":"NA","title":"Tc99m Sestamibi Molecular Breast Imaging","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06-15","conditions":"Breast Cancer","enrollment":96},{"nctId":"NCT07451444","phase":"NA","title":"Core Stability Exercises Versus Tai Chi Exercises on Dynamic Balance After Colo-rectal Surgeries.","status":"COMPLETED","sponsor":"Cairo University","startDate":"2025-02-15","conditions":"Post-Op Complication, Post Colo- Rectal Surgeries, Colo -Rectal Surgeries","enrollment":60},{"nctId":"NCT07443904","phase":"NA","title":"Muévete conCiencia: Exercise and Mind-Body Program for First-Year University Students","status":"NOT_YET_RECRUITING","sponsor":"Universidad San Sebastián","startDate":"2026-03-01","conditions":"Healthy, Healthy Adult Participants","enrollment":120},{"nctId":"NCT07432178","phase":"PHASE3","title":"CDK4/6 Inhibitors Intensification for Chemotherapy Omission in Small Size High-risk ER-positive Breast Cancer（Cinnamon）","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-02-23","conditions":"Breast Cancer","enrollment":2288},{"nctId":"NCT07431216","phase":"PHASE1, PHASE2","title":"A Phase 1b/2a Study to Evaluate the Safety, Pharmacokinetics, and Objective Response of STAR-001 (LP-184) in Combination With Spironolactone in Supratentorial Glioblastoma at First Progression","status":"NOT_YET_RECRUITING","sponsor":"Lantern Pharma Inc.","startDate":"2026-04-01","conditions":"Histopathology Confirmed Supratentorial GBM at First Recurrence, IDHwt GBM, IDHm Grade 4 Astrocytoma","enrollment":68},{"nctId":"NCT07426120","phase":"PHASE3","title":"Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III)","status":"RECRUITING","sponsor":"Psoriasis Research Institute of Guangzhou","startDate":"2026-02-01","conditions":"Psoriasis Vulgaris, Topical Administration, Phase III","enrollment":300},{"nctId":"NCT07102940","phase":"PHASE2","title":"Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"George Washington University","startDate":"2026-05-01","conditions":"Breast Cancer, HER 2 Negative Breast Cancer, HR Positive/HER-2 Negative Breast Cancer","enrollment":50},{"nctId":"NCT07423611","phase":"PHASE2","title":"ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2026-10-01","conditions":"Breast Cancer","enrollment":388},{"nctId":"NCT07409818","phase":"","title":"A Novel Classification in Calcific Tendinitis of the Shoulder: Evaluating MRI Localization and Related Treatment Strategies","status":"RECRUITING","sponsor":"Koç University","startDate":"2025-10-02","conditions":"Calcific Tendinitis of Shoulder","enrollment":400},{"nctId":"NCT07402135","phase":"NA","title":"Fecal Noninvasive Biomarkers Oriented Control Versus Usual Care Strategy in Ulcerative Colitis","status":"NOT_YET_RECRUITING","sponsor":"Qilu Hospital of Shandong University","startDate":"2026-02-10","conditions":"Noninvasive Biomarkers, Ulcerative Colitis (UC)","enrollment":240},{"nctId":"NCT03120624","phase":"PHASE1","title":"VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-09-15","conditions":"Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma","enrollment":34},{"nctId":"NCT07372131","phase":"NA","title":"Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients","status":"RECRUITING","sponsor":"Humanitas University","startDate":"2025-05-10","conditions":"Bloodstream Infection, Gram Negative Infections, Bacteraemia Caused by Gram-Negative Bacteria","enrollment":172},{"nctId":"NCT02900976","phase":"PHASE2","title":"Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2017-03-22","conditions":"EBV-Related Post-Transplant Lymphoproliferative Disorder, Monomorphic Post-Transplant Lymphoproliferative Disorder, Polymorphic Post-Transplant Lymphoproliferative Disorder","enrollment":18},{"nctId":"NCT07358975","phase":"PHASE4","title":"Prediction of Complications in Hepatic Tumors","status":"NOT_YET_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-03","conditions":"Hepatic Tumors","enrollment":192},{"nctId":"NCT05701982","phase":"NA","title":"The Effect of a Technology-Mediated Integrated Walking and Tai Chi Intervention on Physical Function in Veterans With COPD and Chronic Musculoskeletal Pain","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-03","conditions":"COPD, Chronic Musculoskeletal Pain","enrollment":136},{"nctId":"NCT05357027","phase":"PHASE1, PHASE2","title":"HPV16 E6 TCR T Cells for Cervical Carcinoma","status":"TERMINATED","sponsor":"TCRCure Biopharma Ltd.","startDate":"2022-08-10","conditions":"Cervical Carcinoma","enrollment":5},{"nctId":"NCT07242417","phase":"EARLY_PHASE1","title":"TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors","status":"RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2025-12-18","conditions":"Solid Cancer, GPC3 Positive Hepatocellular Carcinoma","enrollment":30},{"nctId":"NCT02856425","phase":"PHASE1","title":"Trial Of Pembrolizumab And Nintedanib","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"2016-11-10","conditions":"Patients With Any Advanced Solid Tumors","enrollment":196},{"nctId":"NCT05924672","phase":"PHASE2","title":"Efficacy of Ra-223 in PSMA PET Optimally Selected Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2024-08-30","conditions":"Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Stage IVB Prostate Cancer AJCC v8","enrollment":2},{"nctId":"NCT05888103","phase":"PHASE3","title":"Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-07-11","conditions":"Primary Hypercholesterolemia or Mixed Dyslipidemia","enrollment":207},{"nctId":"NCT07307053","phase":"PHASE1, PHASE2","title":"Rare Tumor Focused Platform Study of Innovative Therapies and Technologies (PLATFORM2)","status":"NOT_YET_RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2026-01-01","conditions":"Rare Malignant Neoplasm, Advanced Solid Tumors, Metastatic Solid Tumors","enrollment":600},{"nctId":"NCT07063173","phase":"NA","title":"Bioavailability of Ration Items Containing Tart Cherry Extract","status":"RECRUITING","sponsor":"United States Army Research Institute of Environmental Medicine","startDate":"2024-06-14","conditions":"Bioavailability","enrollment":15},{"nctId":"NCT07306663","phase":"PHASE3","title":"Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu Cancer Institute & Hospital","startDate":"2021-06-01","conditions":"Esophageal Cancer","enrollment":242},{"nctId":"NCT05256745","phase":"PHASE1, PHASE2","title":"RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast Cancer","status":"RECRUITING","sponsor":"Georgetown University","startDate":"2023-06-06","conditions":"Cancer Related Cognitive Decline, Non-metastatic Breast Cancer","enrollment":48},{"nctId":"NCT07275463","phase":"PHASE2","title":"[99mTc]Tc-DB8 Accumulation in Primary Tumor in Breast Cancer With Positive and Negative Estrogen Receptor Expression","status":"ENROLLING_BY_INVITATION","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2025-10-01","conditions":"Primary Breast Cancer","enrollment":40},{"nctId":"NCT07292571","phase":"PHASE2","title":"Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107","status":"ENROLLING_BY_INVITATION","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2025-10-20","conditions":"Primary Breast Cancer","enrollment":50},{"nctId":"NCT04690933","phase":"","title":"AntiCMV molécules Monitoring in Real-life in Stem Cell Recipients","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2020-09-24","conditions":"Hematopoietic Stem Cell Transplantation, Cytomegalovirus Infections, Antivirals","enrollment":400},{"nctId":"NCT07271602","phase":"PHASE2","title":"A Phase 2 Randomized, Controlled Trial of QL1706 Plus Chemotherapy and Quad Shot for Driver Gene-negative Advanced Non-small Cell Lung Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-01-30","conditions":"Non Small Cell Lung Cancer, Immunotherapy, Radiotherapy","enrollment":104},{"nctId":"NCT06007586","phase":"PHASE3","title":"Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients","status":"COMPLETED","sponsor":"Sichuan Cancer Hospital and Research Institute","startDate":"2024-05-31","conditions":"Gynecological Tumor, Ovarian Cancer, Cervical Cancer","enrollment":143},{"nctId":"NCT07246304","phase":"EARLY_PHASE1","title":"TC-D101 Cell Therapy for Patients With DLL3-Positive SCLC","status":"RECRUITING","sponsor":"TCRCure Biopharma Ltd.","startDate":"2025-11-30","conditions":"Small Cell Lung Cancer ( SCLC ), CAR-T Cell Therapy","enrollment":24},{"nctId":"NCT03812172","phase":"","title":"Screening for Cardiac Amyloidosis With Nuclear Imaging for Minority Populations","status":"COMPLETED","sponsor":"Mathew S. Maurer, MD","startDate":"2019-05-15","conditions":"Amyloid Cardiomyopathy, Transthyretin-Related","enrollment":646},{"nctId":"NCT07053696","phase":"PHASE1","title":"Pharmacokinetics, Safety, and Lung Deposition of 99mTc-DTPA Delivered Via the EDDIS System in Healthy Volunteers","status":"WITHDRAWN","sponsor":"Andrey Petrov","startDate":"2025-03-17","conditions":"Healthy Volunteers","enrollment":""},{"nctId":"NCT04811313","phase":"NA","title":"Tranexamic Acid in Pediatric Undergoing Proximal Femoral Osteotomies and/or Acetabular Osteotomy","status":"RECRUITING","sponsor":"Assiut University","startDate":"2025-04-03","conditions":"Intraoperative Blood Loss, Pediatric, Orthopedic Disorder","enrollment":400},{"nctId":"NCT02881554","phase":"NA","title":"Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery","status":"TERMINATED","sponsor":"University of Washington","startDate":"2016-12-21","conditions":"Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Stage IV Liver Cancer","enrollment":41},{"nctId":"NCT05042687","phase":"NA","title":"Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-12-13","conditions":"Breast Cancer","enrollment":300},{"nctId":"NCT02744053","phase":"EARLY_PHASE1","title":"DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-11-07","conditions":"Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative","enrollment":96},{"nctId":"NCT02978144","phase":"PHASE2","title":"Lung Imaging of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"Columbia University","startDate":"2017-06-15","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":34},{"nctId":"NCT07212933","phase":"PHASE2","title":"The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled Trial","status":"RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2025-07-01","conditions":"Gastric (Stomach) Cancer, Biological Therapy, Immunotherapy","enrollment":90},{"nctId":"NCT07205445","phase":"","title":"Tensi+ European Registry","status":"RECRUITING","sponsor":"Stimuli Technology","startDate":"2025-02-27","conditions":"Overactive Bladder","enrollment":500},{"nctId":"NCT07205497","phase":"PHASE2","title":"QL1706 Plus Neoadjuvant Chemotherapy Followed by Type I Hysterectomy for Locally Advanced Cervical Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2025-03-28","conditions":"Neoadjuvant Immunotherapy, Locally Advanced Cervical Cancer","enrollment":54},{"nctId":"NCT06058650","phase":"NA","title":"Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2021-08-26","conditions":"Breast Neoplasm","enrollment":70},{"nctId":"NCT03948529","phase":"PHASE2","title":"RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2019-09-05","conditions":"Leukemia, Graft Failure","enrollment":9},{"nctId":"NCT03516812","phase":"PHASE2","title":"Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer","status":"COMPLETED","sponsor":"University of Washington","startDate":"2018-08-29","conditions":"Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma","enrollment":36},{"nctId":"NCT07179341","phase":"NA","title":"Survival Nomogram for Patients With Thymic Carcinoma","status":"COMPLETED","sponsor":"Weijie Ye","startDate":"2024-07-09","conditions":"Thymic Carcinoma","enrollment":156},{"nctId":"NCT04105270","phase":"PHASE2","title":"RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2022-11-30","conditions":"Adenocarcinoma of Lung, Lung Cancer","enrollment":82},{"nctId":"NCT06509568","phase":"PHASE2","title":"Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-08-01","conditions":"Esophageal Squamous Cell Carcinoma","enrollment":92},{"nctId":"NCT05014828","phase":"PHASE2","title":"To Evaluate the Efficacy and Safety of Tislelizumab in Combination With Lenvatinib in Participants With Selected Solid Tumors","status":"COMPLETED","sponsor":"BeiGene","startDate":"2021-09-18","conditions":"Advanced Solid Tumor","enrollment":58},{"nctId":"NCT04047862","phase":"PHASE1","title":"Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors","status":"COMPLETED","sponsor":"BeiGene","startDate":"2019-08-15","conditions":"Locally Advanced and Metastatic Solid Tumors","enrollment":446},{"nctId":"NCT07033364","phase":"","title":"Functional Liver After SBRT","status":"RECRUITING","sponsor":"The Netherlands Cancer Institute","startDate":"2025-07-21","conditions":"Liver Metastases","enrollment":15},{"nctId":"NCT07124377","phase":"","title":"Phenotypic Manifestations of Hereditary ATTR Amyloidosis","status":"ENROLLING_BY_INVITATION","sponsor":"Hospital 9 de Julio de Las Breñas","startDate":"2024-09-01","conditions":"Hereditary Amyloidosis, Transthyretin-Related","enrollment":57},{"nctId":"NCT07121595","phase":"PHASE2","title":"Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial","status":"RECRUITING","sponsor":"University of Michigan Rogel Cancer Center","startDate":"2025-07-17","conditions":"Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8","enrollment":50},{"nctId":"NCT07119034","phase":"","title":"Assessment of Oxidative Stress Contents in Jordanian Pregnant Women With Preeclampsia","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2022-11-01","conditions":"Preeclampsia (PE), Oxidative Stress","enrollment":90},{"nctId":"NCT07112833","phase":"PHASE2","title":"A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC)","status":"NOT_YET_RECRUITING","sponsor":"Hebei Medical University Fourth Hospital","startDate":"2025-08-10","conditions":"Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma","enrollment":36},{"nctId":"NCT06027541","phase":"","title":"Young Patients With Early Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2023-08-01","conditions":"Breast Cancer Female","enrollment":1000},{"nctId":"NCT05980598","phase":"PHASE2","title":"TransCon (TC) TLR7/8 Agonist, TC IL-2 β/γ, Pembrolizumab Prior to Surgery for Advanced Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","sponsor":"Ascendis Pharma A/S","startDate":"2023-09-29","conditions":"Head and Neck Neoplasms","enrollment":27},{"nctId":"NCT05881525","phase":"PHASE1","title":"NY-ESO-1 TCR-T Cells for NY-ESO-1 Positive Subjects With Advanced Solid Tumors","status":"RECRUITING","sponsor":"TCRCure Biopharma Ltd.","startDate":"2023-06-01","conditions":"Advanced Solid Tumors","enrollment":18},{"nctId":"NCT07062081","phase":"NA","title":"Correlation Between Acne Vulgaris and Lipid Profile Among Young Adults in Sohag Governorate","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-08-01","conditions":"Acne Vulgaris","enrollment":100},{"nctId":"NCT06371404","phase":"","title":"Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-06-05","conditions":"Alcohol Use Disorder, Post Traumatic Stress Disorder","enrollment":150},{"nctId":"NCT00832429","phase":"PHASE2","title":"Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2009-02-25","conditions":"Eyelid Sebaceous Gland Carcinoma","enrollment":20},{"nctId":"NCT01564056","phase":"PHASE3","title":"Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2012-04-12","conditions":"Breast Cancer","enrollment":1989},{"nctId":"NCT06066749","phase":"NA","title":"Efficacy of Respiratory Protection Against the Effects of Wood Smoke Exposure in Young Healthy Adults","status":"SUSPENDED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2024-06-01","conditions":"Healthy","enrollment":50},{"nctId":"NCT06454617","phase":"","title":"Calibr-Ì: Comparative Evaluation of Phantomless Calibration Methods to Quantify Bone Mineral Density for Opportunistic Analysis of CT Scans","status":"RECRUITING","sponsor":"Istituto Ortopedico Rizzoli","startDate":"2024-06-06","conditions":"Osteoporosis","enrollment":100},{"nctId":"NCT06520020","phase":"NA","title":"Evaluating Safety and Feasibility of Transcutaneous Spinal Cord Stimulation Following Traumatic and Non-Traumatic Spinal Cord Injury: A Pilot Study","status":"RECRUITING","sponsor":"Francis Farhadi","startDate":"2024-10-23","conditions":"Spinal Cord Stimulation, Electric Stimulation Therapy, Traumatic Spinal Cord Injury","enrollment":30},{"nctId":"NCT07005557","phase":"PHASE3","title":"Chemo-free in Older (≥65) Node-Positive ER+/HER2- Breast Cancer","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-06-15","conditions":"Breast Cancer, Adjuvant Therapy","enrollment":1244},{"nctId":"NCT06996093","phase":"PHASE3","title":"Chemotherapy Omission in HR-positive/HER2-negative Breast Cancer With Lymph Node Negative Disease Receiving Adjuvant Endocrine Therapy and CDK4/6 Inhibitor","status":"NOT_YET_RECRUITING","sponsor":"Fudan University","startDate":"2025-06-02","conditions":"Breast Cancer","enrollment":2508},{"nctId":"NCT01783145","phase":"","title":"Shared Care Follow-up After Chemotherapy for Testicular Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Medical Center Groningen","startDate":"2012-10","conditions":"Testicular Cancer","enrollment":163},{"nctId":"NCT06987123","phase":"PHASE2","title":"TC as Adjuvant Therapy After Surgery for Locally Recurrent Resectable Nasopharyngeal Carcinoma: a Single-arm Clinical Trial","status":"NOT_YET_RECRUITING","sponsor":"Sun Yat-sen University","startDate":"2025-05-18","conditions":"Nasopharyngeal Carcinoma (NPC)","enrollment":62},{"nctId":"NCT06915857","phase":"PHASE3","title":"Topical Betamethasone Versus Moisturizer in Preventing Radiation Dermatitis in Large-Breasted Patients Treated in the Prone Position","status":"RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2025-02-26","conditions":"Breast Cancer, Radiation Dermatitis","enrollment":276},{"nctId":"NCT04183790","phase":"PHASE3","title":"Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA TC Combination Therapy in Participants With Cystic Fibrosis Who Are 6 Years of Age and Older","status":"COMPLETED","sponsor":"Vertex Pharmaceuticals Incorporated","startDate":"2020-02-17","conditions":"Cystic Fibrosis","enrollment":64},{"nctId":"NCT05299632","phase":"","title":"F-18 PSMA for Localization of Parathyroid Adenoma","status":"TERMINATED","sponsor":"Emory University","startDate":"2022-03-31","conditions":"Hyperparathyroidism","enrollment":3},{"nctId":"NCT02693665","phase":"NA","title":"Building Evidence for Effective Palliative/End of Life Care for Teens With Cancer","status":"COMPLETED","sponsor":"Maureen Lyon","startDate":"2016-07-16","conditions":"Cancer","enrollment":260},{"nctId":"NCT06723028","phase":"NA","title":"Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls","status":"RECRUITING","sponsor":"University of Wyoming","startDate":"2025-02-01","conditions":"Obesity and Type 2 Diabetes, Diet Modification","enrollment":150},{"nctId":"NCT06928532","phase":"NA","title":"Seated Tai Chi Improves Dynamic Finger Pointing Task and Sitting Balance Control in Subjects With Parkinson's Disease","status":"COMPLETED","sponsor":"The Hong Kong Polytechnic University","startDate":"2018-10-29","conditions":"Parkinson's Disease and Parkinsonism, Tai Chi","enrollment":56},{"nctId":"NCT06927518","phase":"NA","title":"Effects of Receptive Language Intervention vs Individual Therapy for Preschool Children With Autism Spectrum Disorder.","status":"RECRUITING","sponsor":"Riphah International University","startDate":"2025-03-20","conditions":"Autism Spectrum Disorder","enrollment":30},{"nctId":"NCT02119065","phase":"","title":"Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cincinnati","startDate":"2014-01-30","conditions":"Advanced Adult Primary Liver Cancer, Liver Metastases, Localized Unresectable Adult Primary Liver Cancer","enrollment":6},{"nctId":"NCT05710042","phase":"","title":"ALIVE Expended Access - Clinical Study","status":"NO_LONGER_AVAILABLE","sponsor":"BioVentrix","startDate":"","conditions":"Heart Failure, Left Ventricle Remodeling","enrollment":""},{"nctId":"NCT03845127","phase":"NA","title":"Randomized Evaluation and Verification of Ventricular Enhancement","status":"WITHDRAWN","sponsor":"BioVentrix","startDate":"2020-01-01","conditions":"Ischemic Cardiomyopathy, Heart Failure","enrollment":""},{"nctId":"NCT06918678","phase":"NA","title":"Feasibility and Efficacy of A Remote Tai Chi Program in Older Adults","status":"COMPLETED","sponsor":"The University of Tennessee, Knoxville","startDate":"2023-03-20","conditions":"Aging","enrollment":35},{"nctId":"NCT03230006","phase":"NA","title":"Transdiagnostic CBT for Comorbid Alcohol Use and Anxiety Disorders","status":"COMPLETED","sponsor":"Boston University Charles River Campus","startDate":"2018-03-01","conditions":"Alcohol Use Disorder, Anxiety Disorders","enrollment":75},{"nctId":"NCT05923268","phase":"NA","title":"Molecular Imaging of HER2 Expression in Breast Cancer Using [99mTc]Tc-G3-(G3S)3C Before Chemo/Targeted Therapy","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2023-06-04","conditions":"Breast Cancer Female","enrollment":10},{"nctId":"NCT05940298","phase":"PHASE1","title":"Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2023-07-03","conditions":"Prostate Cancer, Breast Cancer","enrollment":10},{"nctId":"NCT05620472","phase":"PHASE1","title":"Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2022-10-01","conditions":"Solid Tumor, Adult","enrollment":10},{"nctId":"NCT06101927","phase":"PHASE1","title":"Molecular Imaging of Prostate-Specific Membrane Antigen Using Labeled Technetium-99m BQ0413","status":"COMPLETED","sponsor":"Tomsk National Research Medical Center of the Russian Academy of Sciences","startDate":"2023-10-19","conditions":"Prostate Cancer","enrollment":10},{"nctId":"NCT01394679","phase":"PHASE3","title":"A Phase 3 Study of 99mTC-EC-DG SPECT/CT Versus PET/CT in Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"Cell>Point LLC","startDate":"2025-05-01","conditions":"Lung Cancer","enrollment":154},{"nctId":"NCT05410821","phase":"PHASE1","title":"Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer","status":"COMPLETED","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2022-06-15","conditions":"Refractory Thyroid Gland Carcinoma, Refractory Thyroid Gland Papillary Carcinoma, Refractory Thyroid Gland Follicular Carcinoma","enrollment":12},{"nctId":"NCT05352074","phase":"NA","title":"STOPS Trial: Total vs Subtotal Colectomy for Slow Transit Constipation","status":"RECRUITING","sponsor":"Third Military Medical University","startDate":"2022-03-27","conditions":"Slow Transit Constipation, Surgery","enrollment":252}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[{"date":"20220517","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"ANDA078098"},{"date":"20080922","type":"ORIG","sponsor":"CURIUM","applicationNumber":"ANDA078098"},{"date":"20150409","type":"SUPPL","sponsor":"CURIUM","applicationNumber":"ANDA078098"},{"date":"20230130","type":"ORIG","sponsor":"JUBILANT DRAXIMAGE","applicationNumber":"NDA216820"},{"date":"20150910","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19850930","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"20140221","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19930324","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19810413","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"20250522","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19940321","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19810217","type":"ORIG","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"20201113","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19930324","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19970304","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"20081126","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19820412","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19991123","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"19920930","type":"SUPPL","sponsor":"CARDINAL HEALTH 414","applicationNumber":"NDA018107"},{"date":"20250326","type":"ORIG","sponsor":"CURIUM","applicationNumber":"ANDA215146"},{"date":"20180501","type":"SUPPL","sponsor":"JUBILANT DRAXIMAGE","applicationNumber":"ANDA078806"},{"date":"20090429","type":"ORIG","sponsor":"JUBILANT DRAXIMAGE","applicationNumber":"ANDA078806"}],"publicationCount":89428,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Paclitaxel/Carboplatin","Docetaxel plus cyclophosphamide"],"phase":"marketed","status":"active","brandName":"TC","genericName":"TC","companyName":"AGO Study Group","companyId":"ago-study-group","modality":"Small molecule","firstApprovalDate":"","aiSummary":"TC is a chemotherapy regimen combining docetaxel and cyclophosphamide, which work synergistically to inhibit cell division and induce apoptosis in cancer cells. Used for Breast cancer (adjuvant and neoadjuvant treatment).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}